CRI Speaks

Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming CRI Speaks

September 22, 20203:00 PM

FierceBiotech Roundtable Webinar: ​ESMO Post-Show: Highlights from the virtual conference

CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "​ESMO Post-Show" webinar on September 22, 2020, at 3 PM ET.

October 01, 20209:00 AM

Fifth Annual IO Combinations 360°

CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "Public-Private Partnerships Between Research Organizations and BioPharma to Accelerate Cancer Immunotherapies" panel on October 2, 2020, at 1 PM ET. 

Past CRI Speaks

June 24, 202011:00 AM
CRI Speaks

FUSF Webinar: Cancer Immunotherapy Treatment and Research in a COVID-19 World

The Focused Ultrasound Foundation (FUSF) hosts a special conversation with Jill O’Donnell-Tormey, Ph.D., CEO of the Cancer Research Institute (CRI), and Jessica Foley, Ph.D., chief scientific officer of FUSF.

May 27, 20203:00 PM
CRI Speaks

FiercePharma Virtual's ASCO Preview: What to Watch For

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "ASCO Preview" webinar on May 27, 2020, at 3 p.m. ET. 

May 26, 20209:00 AM
CRI Speaks

Sixth Annual Digital Immuno-Oncology Innovation Forum

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investor Panel" on May 27, 2020, at 12 p.m. CT. 

May 05, 20209:00 AM
CRI Speaks

31st Annual Cancer Progress Conference

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.

February 26, 20209:00 AM
CRI Speaks

Sixth Annual Immuno-Oncology 360° Summit

CRI’s Vanessa Lucey, Ph.D., MBA, speaks on the "Landscape and Evolution of the Marketplace" panel on February 27, 2020.

December 04, 201911:30 AM
CRI Speaks

The Biotech’s Conundrum in Immuno-Oncology: Between a Rock and a Hard Place – Weighing Hot Versus Cold Tumors, CPI-Naïve Versus CPI-Experienced Patients

CRI's Vanessa Lucey, Ph.D., discusses the immuno-onocology landscape in this webinar for the biotechnology industry. 

December 02, 20191:00 PM
CRI Speaks

World Vaccine & Immunotherapy Congress West Coast 2019

On December 4, CRI's Vanessa Hubbard-Lucey, Ph.D., MBA, is giving a talk on "Challenges and opportunities in designing immuno-oncology trials: A non-profit perspective."

November 07, 20199:00 AM
CRI Speaks

Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting

CRI's Vanessa Lucey is presenting a poster on our prostate cancer clinical trial in conjunction with our partners. 

November 05, 20199:00 AM
CRI Speaks

FNIH Biomarkers Consortium 2019 CSC Scientific Symposium

CRI's Jun Tang, Ph.D., senior manager, CRI Venture Fund and Clinical Accelerator, is presenting the latest update on the PD1/L1 landscape. 

May 07, 20197:00 AM
CRI Speaks

30th Annual Cancer Progress Conference

Drs. Jill O'Donnell-Tormey and Vanessa M. Lucey are participating in panel discussions at Cancer Progress.

*Immunotherapy results may vary from patient to patient.